Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis
Author(s) -
Laure Gineau,
David Courtin,
Mamadou Camara,
Hamidou Ilboudo,
Vincent Jamonneau,
Fabrício C. Dias,
Léonidas Tokplonou,
Jacqueline Milet,
Priscila Baptista Mendonça,
Erick C. Castelli,
Oumou Camara,
Mariam Camara,
Benoı̂t Favier,
Nathalie RouasFreiss,
Philippe Moreau,
Eduardo Antônio Donadi,
Bruno Bucheton,
Audrey Sabbagh,
André Garcia
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw505
Subject(s) - african trypanosomiasis , human leukocyte antigen , antigen , medicine , immunology , serology , hla g , stage (stratigraphy) , trypanosomiasis , disease , antibody , trypanosoma brucei , parasitology , biology , pathology , genetics , gene , paleontology
Human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense can be diagnosed in the early hemolymphatic stage (stage 1 [S1]) or meningoencephalitic stage (stage 2 [S2]). Importantly, individuals harbouring high and specific antibody responses to Tbg antigens but negative parasitology are also diagnosed in the field (seropositive [SERO]). Whereas some develop the disease in the months following their initial diagnosis (SERO/HAT), others remain parasitologically negative for long periods (SERO) and are apparently able to control infection. Human leucocyte antigen (HLA)-G, an immunosuppressive molecule, could play a critical role in this variability of progression between infection and disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom